The amount of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia.

被引：0
|
作者：
Venditti, A [1 ]
Buccisano, F [1 ]
Tamburini, A [1 ]
Del Poeta, G [1 ]
Maurillo, L [1 ]
Del Moro, B [1 ]
Epiceno, AM [1 ]
Amadori, S [1 ]
机构：
[1] Univ Rome Tor Vergata, Rome, Italy
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3074
引用
收藏
页码：695A / 695A
页数：1
相关论文
共 50 条
  • [21] Leukemia derived dendritic cells in acute myeloid leukemia. A new immunotherapeutic modality in minimal residual disease?
    van de Loosdrecht, AA
    Westers, TM
    Scheper, RJ
    Ossenkoppele, GJ
    [J]. LEUKEMIA, 2001, 15 (03) : 494 - 494
  • [22] Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia.
    Steinbach, D
    Schramm, A
    Eggert, A
    Wittig, S
    Pfaffendorf, N
    Voigt, A
    Zintl, F
    Gruhn, B
    [J]. BLOOD, 2005, 106 (11) : 422A - 422A
  • [23] Quantitative assessment of minimal residual disease predicts outcome of patients of acute myeloid leukemia with Nucleophosmin (NPM) mutation.
    Chou, Wen-Chien
    Tang, Jih-Luh
    Wu, Shang-Ju
    Yao, Ming
    Tien, Hwei-Fang
    [J]. BLOOD, 2006, 108 (11) : 169A - 169A
  • [24] Development of minimal residual disease-directed therapy in acute myeloid leukemia
    Freeman, Sylvie D.
    Jovanovic, Jelena V.
    Grimwade, David
    [J]. SEMINARS IN ONCOLOGY, 2008, 35 (04) : 388 - 400
  • [25] Minimal Residual Disease Quantitation in Acute Myeloid Leukemia
    Shook, David
    Coustan-Smith, Elaine
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Campana, Dario
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S281 - S285
  • [26] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Jongen-Lavrencic, M.
    Grob, T.
    Hanekamp, D.
    Kavelaars, F. G.
    al Hinai, A.
    Zeilemaker, A.
    Erpelinck-Verschueren, C. A. J.
    Gradowska, P. L.
    Meijer, R.
    Cloos, J.
    Biemond, B. J.
    Graux, C.
    Kooy, M. van Marwijk
    Manz, M. G.
    Pabst, T.
    Passweg, J. R.
    Havelange, V.
    Ossenkoppele, G. J.
    Sanders, M. A.
    Schuurhuis, G. J.
    Lowenberg, B.
    Valk, P. J. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1189 - 1199
  • [27] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA PATIENTS
    Van der Velden, Vincent
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 416 - 416
  • [28] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Mauvieux, Laurent
    Miguet, Laurent
    Fornecker, Luc
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25): : 2442 - +
  • [29] Monitoring of minimal residual disease in acute myeloid leukemia
    Kern, W
    Schoch, C
    Haferlach, T
    Schnittger, S
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (02) : 283 - 309
  • [30] The amount of spontaneous apoptosis predicts outcome in acute myeloid leukemia (AML).
    Del Poeta, G
    Venditti, A
    Maurillo, L
    Buccisano, F
    Del Moro, B
    Suppo, G
    Epiceno, AM
    Cox, MC
    Masi, M
    Amadori, S
    [J]. BLOOD, 2000, 96 (11) : 543A - 543A
12345